3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Melanoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Glioblastoma
1
Esophageal Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Carcinoma, Bronchogenic
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
11
trametinib
8
selpercatinib
7
pembrolizumab
7
dabrafenib
7
Nivolumab
7
Iodine-131
6
lenvatinib
5
Specimen Handling
5
Biopsy
5
cabozantinib
4
Vemurafenib
4
Iodine-124
4
larotrectinib
3
durvalumab
3
binimetinib
3
anlotinib
3
Ipilimumab
3
Immunoglobulin G
3
Fluorodeoxyglucose F18
3
Disulfides
3
Cyclophosphamide
3
Cetuximab
3
vandetanib
2
ulixertinib
2
pralsetinib
2
omipalisib
2
defactinib
2
copanlisib
2
cemiplimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Interleukin-15
×
1 year
×
Clear all
No trials found.